The Latest Breaking News from FDA

It's a major turnaround for a drug company that warned last year about its ability to stay in business.

Government sources had indicated flights would begin in July, but order shows first could happen on 24 June

Moderna stock toppled Friday after the FDA delayed an approval decision on its RSV vaccine until the end of the month.

Move intended to boost standards and attract recruits from private sector criticised as ‘tinkering’ by FDA union

It is unclear why the suggested rule was not released by its intended deadline. But a spokesperson for the federal agency told NPR that its implementation "continues to be a high priority."

Discover how incorporating yogurt into your diet can help reduce the risk of type 2 diabetes, as approved by the FDA.

FDA allows yogurt producers to claim reduced Type 2 diabetes risk despite limited evidence. Consumers advised to critically evaluate labeling claims.

Samsung already has passive AFib detection of irregular heart rhythm. This new patent will use generative AI to convert PPG data into ECG graphs — and we're intrigued.

The popular drink has been a morning and lunchtime staple for decades.

"There's not enough profit" for drug-makers in life-saving cancer meds, and the FDA can't force them

Amid increasing healthcare spending, breakthroughs in genomics and personalized medicine, and the adoption of new technologies, the pharma industry is booming. So, let’s analyze Eli Lilly (LLY) and Pfizer (PFE) to determine which pharma stock will surge from their first-quarter earnings. Read on to find out.